Published in Pediatr Nephrol on May 27, 2008
Growth hormone treatment started in the first year of life in infants with chronic renal failure. Pediatr Nephrol (2009) 2.21
The consequences of chronic kidney disease on bone metabolism and growth in children. Nephrol Dial Transplant (2012) 1.02
Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia. Pediatr Nephrol (2010) 0.95
Middle-term use of Cinacalcet in paediatric dialysis patients. Pediatr Nephrol (2009) 0.89
An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects. Pediatr Nephrol (2012) 0.87
Mineral and bone disorders in children with chronic kidney disease. Nat Rev Nephrol (2011) 0.81
New therapies: calcimimetics, phosphate binders and vitamin D receptor activators. Pediatr Nephrol (2010) 0.81
Calcimimetics in CKD-results from recent clinical studies. Pediatr Nephrol (2008) 0.78
Growth-plate cartilage in chronic renal failure. Pediatr Nephrol (2009) 0.78
Pre-treatment considerations in childhood hypertension due to chronic kidney disease. World J Nephrol (2015) 0.75
Cinacalcet administration by gastrostomy tube in a child receiving peritoneal dialysis. J Pediatr Pharmacol Ther (2014) 0.75
Cinacalcet in pediatric and adolescent chronic kidney disease: a single-center experience. Medicine (Baltimore) (2015) 0.75
Cinacalcet as adjunctive therapy in pseudohypoparathyroidism type 1b. Pediatr Nephrol (2015) 0.75
Pubertal development in children with chronic kidney disease. Pediatr Nephrol (2016) 0.75
Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder. Curr Osteoporos Rep (2017) 0.75
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med (2000) 8.47
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med (2004) 6.52
Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation (2002) 2.47
The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol (2002) 2.18
Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci U S A (1998) 2.05
Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. J Clin Pathol (1979) 1.95
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism. Kidney Int (2003) 1.82
Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest (1997) 1.79
First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl. Kidney Int (2005) 1.74
Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol Dial Transplant (2006) 1.67
The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int (1997) 1.52
Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate. Clin J Am Soc Nephrol (2006) 1.36
The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease. J Am Soc Nephrol (2003) 1.35
Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl. Nephrol Dial Transplant (2005) 1.33
Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med (2000) 1.28
Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Nephrol Dial Transplant (2006) 1.06
Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int (1998) 1.05
Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy. N Engl J Med (1978) 1.04
Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials. Pediatr Nephrol (2003) 0.93
Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Transplantation (2006) 0.92
Pubertal growth in chronic renal failure. Pediatr Res (1990) 0.91
Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation. Transplantation (2007) 0.91
Pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis (1994) 0.88
A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. Am J Kidney Dis (2006) 0.86
Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats. Kidney Int (2000) 0.80
Short dialyzed children respond less to growth hormone than patients prior to dialysis. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Nephrol (1996) 0.79
Circulating inhibitor of gonadotropin releasing hormone secretion by hypothalamic neurons in uremia. Kidney Int (2002) 0.78
Growth hormone treatment of short children with chronic renal failure before and after renal transplantation: rationale and recent results. Nephrol Dial Transplant (1996) 0.75
Strict blood-pressure control and progression of renal failure in children. N Engl J Med (2009) 5.71
Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol (2012) 2.83
Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial. Circ Cardiovasc Interv (2013) 2.69
An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis (2012) 1.79
Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats. Nephrol Dial Transplant (2010) 1.68
Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics (2007) 1.68
Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol Dial Transplant (2006) 1.67
Normal adult height after steroid-withdrawal within 6 months of pediatric kidney transplantation: a 20 years single center experience. Transpl Int (2011) 1.46
The effect of sevelamer on the pharmacokinetics of cyclosporin A and mycophenolate mofetil after renal transplantation. Nephrol Dial Transplant (2004) 1.42
Hemophagocytic lymphohistiocytosis and Kawasaki disease: combined manifestation and differential diagnosis. Pediatr Blood Cancer (2009) 1.31
Imaging and quantification of subbasal nerve plexus in healthy volunteers and diabetic patients with or without retinopathy. PLoS One (2013) 1.14
The PROGINS polymorphism of the human progesterone receptor diminishes the response to progesterone. J Mol Endocrinol (2007) 1.09
Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis. J Thorac Cardiovasc Surg (2011) 1.09
Reference values of aortic pulse wave velocity in a large healthy population aged between 3 and 18 years. J Hypertens (2013) 1.08
Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD). Nephrol Dial Transplant (2009) 1.08
Demographic, clinical and treatment related predictors for event-free probability following low-dose radiotherapy for painful heel spurs - a retrospective multicenter study of 502 patients. Acta Oncol (2007) 1.06
DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome. Pediatr Nephrol (2010) 1.05
Aminoglycoside pretreatment partially restores the function of truncated V(2) vasopressin receptors found in patients with nephrogenic diabetes insipidus. J Clin Endocrinol Metab (2002) 1.02
Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase. Ann Clin Biochem (2012) 1.02
Effect of renal transplantation in childhood on longitudinal growth and adult height. Kidney Int (2004) 1.02
Nephrotic syndrome and rituximab: facts and perspectives. Pediatr Nephrol (2009) 1.01
Intrarenal abscesses due to Ureaplasma urealyticum in a transplanted kidney. J Clin Microbiol (2007) 1.00
Mapping candidate regions and genes for congenital anomalies of the kidneys and urinary tract (CAKUT) by array-based comparative genomic hybridization. Nephrol Dial Transplant (2010) 0.99
Strategies for subacute/chronic type B aortic dissection: the Investigation Of Stent Grafts in Patients with type B Aortic Dissection (INSTEAD) trial 1-year outcome. J Thorac Cardiovasc Surg (2010) 0.98
Factors predicting the near-final height in growth hormone-treated children and adolescents with chronic kidney disease. J Clin Endocrinol Metab (2008) 0.98
Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study. J Clin Endocrinol Metab (2014) 0.97
Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J Cell Mol Med (2009) 0.94
Dissecting the genotype in syndromic intellectual disability using whole exome sequencing in addition to genome-wide copy number analysis. Hum Genet (2013) 0.94
Isolated sarcoid granulomatous interstitial nephritis responding to infliximab therapy. Am J Kidney Dis (2005) 0.93
Postoperative infections due to bladder catheters after anterior colporrhaphy: a prospective, randomized three-arm study. Int Urogynecol J (2010) 0.92
Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome. Pediatr Nephrol (2014) 0.90
NPHS2 mutation associated with recurrence of proteinuria after transplantation. Pediatr Nephrol (2004) 0.90
Effects of physical therapy on quality of life in osteoporosis patients - a randomized clinical trial. Health Qual Life Outcomes (2012) 0.90
CHD1L: a new candidate gene for congenital anomalies of the kidneys and urinary tract (CAKUT). Nephrol Dial Transplant (2011) 0.89
Pediatric reference values of carotid-femoral pulse wave velocity determined with an oscillometric device. J Hypertens (2012) 0.88
1,25-Dihydroxyvitamin D3-induced aortic calcifications in experimental uremia: up-regulation of osteoblast markers, calcium-transporting proteins and osterix. J Hypertens (2011) 0.88
Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma. Histopathology (2010) 0.87
Impaired skin microcirculation in paediatric patients with type 1 diabetes mellitus. Cardiovasc Diabetol (2013) 0.87
Growth and maturation improvement in children on renal replacement therapy over the past 20 years. Pediatr Nephrol (2013) 0.86
A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. Am J Kidney Dis (2006) 0.86
Growth impairment shows an age-dependent pattern in boys with chronic kidney disease. Pediatr Nephrol (2006) 0.86
(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation. Transpl Int (2012) 0.86
Non-bridging external fixation employing multiplanar K-wires versus volar locked plating for dorsally displaced fractures of the distal radius. Arch Orthop Trauma Surg (2013) 0.85
Fetuin-A serum concentrations in healthy children. Ann Clin Biochem (2009) 0.85
Manual treatment effects to the upper cervical apophysial joints before, during, and after endotracheal anesthesia: a placebo-controlled comparison. Am J Phys Med Rehabil (2005) 0.84
Short-term growth hormone treatment and microcirculation: effects in patients with chronic kidney disease. Microvasc Res (2009) 0.84
Cardiovascular risk and mineral bone disorder in patients with chronic kidney disease. Kidney Blood Press Res (2013) 0.84
Impact of preoperative variables on the functional and radiological outcome of an uncemented femoral stem: a prospective two-year follow-up. Hip Int (2010) 0.84
Body growth after combined liver-kidney transplantation in children with primary hyperoxaluria type 1. Transplantation (2006) 0.84
Activity of childhood lupus nephritis is linked to altered T cell and cytokine homeostasis. J Clin Immunol (2012) 0.84
Effect of alcohol consumption on the liver detoxication capacity as measured by [13C]methacetin- and [methyl-13C]methionine-breath tests. Isotopes Environ Health Stud (2008) 0.83
Can bisphosphonates play a role in the treatment of children with chronic kidney disease? Pediatr Nephrol (2011) 0.83
Assessment of the cardiovascular system in pediatric chronic kidney disease: a pilot study. Pediatr Nephrol (2008) 0.83
Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis. J Rheumatol (2004) 0.83
Circulating endothelial cells demonstrate an attenuation of endothelial damage by minimizing the extracorporeal circulation. J Thorac Cardiovasc Surg (2006) 0.82
Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer. Cancer Gene Ther (2002) 0.82
Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study. Clin Infect Dis (2012) 0.82
The influence in airforce soldiers through wearing certain types of army-issue footwear on muscle activity in the lower extremities. Open Orthop J (2011) 0.82
Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets. Pediatr Nephrol (2010) 0.82
Autologous valve replacement-CD133+ stem cell-plus-fibrin composite-based sprayed cell seeding for intraoperative heart valve tissue engineering. Tissue Eng Part C Methods (2010) 0.81
Arterial microcalcification in atherosclerotic patients with and without chronic kidney disease: a comparative high-resolution scanning X-ray diffraction analysis. Calcif Tissue Int (2012) 0.81
B cell depletion for autoimmune diseases in paediatric patients. Clin Rheumatol (2010) 0.81
Arterial stiffness is increased in asthmatic children. Eur J Pediatr (2014) 0.80
Birth parameters and parental height predict growth outcome in children with chronic kidney disease. Pediatr Nephrol (2013) 0.80
Unruptured pregnancy in a non-communicating heterotopic right fallopian tube associated with left unicornuate uterus: evidence for transperitoneal sperm and oocyte migration. Acta Obstet Gynecol Scand (2002) 0.80
Ceramic femoral components in total knee arthroplasty - two year follow-up results of an international prospective multi-centre study. Open Orthop J (2012) 0.80
Predicting the response to growth hormone treatment in short children with chronic kidney disease. J Clin Endocrinol Metab (2009) 0.80
No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteers. Eur J Clin Pharmacol (2008) 0.80
The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose. Eur J Clin Pharmacol (2005) 0.80
Markers of childhood lupus nephritis indicating disease activity. Pediatr Nephrol (2010) 0.80
Early kidney transplantation improves neurocognitive outcome in patients with severe congenital chronic kidney disease. Transpl Int (2015) 0.79
Soluble VEGF receptor 1 promotes endothelial injury in children and adolescents with lupus nephritis. Pediatr Nephrol (2011) 0.79
Comparative Study of Clinical and Radiological Outcomes of Unconstrained Bicondylar Total Knee Endoprostheses with Anti-allergic Coating. Open Orthop J (2011) 0.79
Cementless total hip replacement: a prospective clinical study of the early functional and radiological outcomes of three different hip stems. Arch Orthop Trauma Surg (2010) 0.79
Endolymphatic non-langerhans cell histiocytosis of the larynx: report of an uncommon disease manifestation. J Pediatr Hematol Oncol (2010) 0.79
Estimated one-yr glomerular filtration rate is an excellent predictor of long-term graft survival in pediatric first kidney transplants. Pediatr Transplant (2008) 0.78